Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is what the FFCD 11-01 - PRODIGE 25 trial proposes to study, as a preliminary for strategic studies evaluating the usefulness of including targeted therapeutics from the first line with aflibercept +/- LV5FU2.
Epistemonikos ID: 6df5633c188a59b2f312961bbab06b5acdc34632
First added on: May 12, 2024